CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
0.76
0.02 (2.11%)
At close: May 01, 2025, 3:59 PM
0.74
-1.97%
After-hours: May 01, 2025, 07:52 PM EDT
CytomX Therapeutics Revenue
CytomX Therapeutics reported an annual revenue of $138.1M, reflecting a 36.45% growth. For the quarter ending December 31, 2024, CytomX Therapeutics generated $38.09M in revenue.
Revenue (ttm)
$138.1M
Revenue Growth
36.45%
Price / Sales Ratio
0.63
Revenue / Employee
$1.16M
Employees
119
Market Cap
60.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 138.1M | +36.45% |
| Dec 31, 2023 | 101.21M | +90.38% |
| Dec 31, 2022 | 53.16M | -23.59% |
| Dec 31, 2021 | 69.57M | -30.68% |
| Dec 31, 2020 | 100.36M | n/a |